794: Crizotinib is an allosteric ABL-inhibitor targeting both native BCR/ABL and BCR/ABL-T315I in vitro and in vivo models of PH+ leukemia

✍ Scribed by Mahajna, J.; Khamaisie, H.; Ruimi, N.; Agbarya, A.; Eshel, E.; Dally, N.; Ottmann, O.; Biondi, R.; Mian, A.A.; Ruthardt, M.

• Book ID: 125794742
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 82 KB
• Volume: 50
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(14)50699-5